FDA – Page 66 – Policy & Medicine

FDA Direct to Consumer Proposed Rule: Advertising Coalition’s Response

FDA Turns to CME for Risk Evaluation and Mitigation Strategy (REMS) Pain Education

FDA – PDUFA Monthly Meetings Beginning July 1, 2010

FDA Proposed Rule on Falsification of Data

Research America Study: American’s Confident in FDA and Biomedical Research

FDA: Off Label May Be the Wrong Label

IOM: Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease

FDA Transparency Initiative: Draft Disclosure Policies

Forbes: FDA Overregulation of Off Label Promotion

FDA: Bad Ad Program – How to Train Your Sales Rep